bcbs glp 1 coverage Medicare GLP-1 Drug Blue Cross Blue Shield
Description
A large new study suggests that GLP-1 receptor agonists may offer more protection against dementia in patients with type 2 diabetes mellitus than metformin, the long-established first-line treatment
Although comparisons between tirzepatide and higher doses of dulaglutide (e.g., 4.5 mg) have yet to be done, these data argue against the concept that GIP coagonism can reduce the risk of GI adverse events
Legislative changes beginning in 2024 and expanding through 2026 have partially reversed this exclusion, though coverage remains more limited than commercial plans
About the Panelists Melanie G
As research continues, the role of GLP-1 therapies in improving blood pressure and long-term health outcomes will likely become even more significant
However, Park says the type of GLP-1 and how much of it you take may have an effect
